BioNTech predicts return to revenue growth in 2025

cafead

Administrator
Staff member
  • cafead   Jan 09, 2024 at 09:52: AM
via BioNTech (22UAy.DE) said on Tuesday it expects to return to revenue growth in 2025 when the ongoing decline in its COVID-19 vaccine business would bottom out, and that it would invest to scale up its oncology business thereafter.

article source
 

<